{"id":1108,"date":"2024-10-14T00:29:07","date_gmt":"2024-10-13T16:29:07","guid":{"rendered":"https:\/\/cytoarm.com\/?p=1108"},"modified":"2024-10-21T12:13:01","modified_gmt":"2024-10-21T04:13:01","slug":"cytoarm-patent-news","status":"publish","type":"post","link":"https:\/\/cytoarm.com\/zh\/post\/1108\/","title":{"rendered":"CytoArm Patent Overview (Updated)"},"content":{"rendered":"<h3 class=\"wp-block-heading\" id=\"cytoarm-s-global-patent-portfolio\"><strong>CytoArm&#8217;s Global Patent Portfolio<\/strong><\/h3>\n\n\n\n<p>At CytoArm, we are pioneering innovative cancer treatment solutions through our <strong>Armed-T platform<\/strong>. Our expansive and growing patent portfolio demonstrates the strength and uniqueness of our cutting-edge technology. Below are key milestones showcasing our global patent filings, approvals, and successes.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"patent-filing-and-approval-milestones\"><strong>Patent Filing and Approval Milestones<\/strong><\/h3>\n\n\n\n<div class=\"wp-block-greenshift-blocks-tabs gspb-tabs gspb_tabs-id-gsbp-d8e9962 gstabs-tabs\" data-autoplay=\"false\" data-autoplaytime=\"4\"><div class=\"t-btn-container\" role=\"tablist\"><button class=\"t-btn active\" aria-selected=\"true\" role=\"tab\" tabindex=\"0\" id=\"gspb-tab-item-btn-gsbp-d8e9962-0\" aria-controls=\"gspb-tab-item-content-gsbp-d8e9962-0\"><div class=\"tabtitlelabel\">2017-2020<\/div><\/button><button class=\"t-btn\" aria-selected=\"false\" role=\"tab\" tabindex=\"-1\" id=\"gspb-tab-item-btn-gsbp-d8e9962-1\" aria-controls=\"gspb-tab-item-content-gsbp-d8e9962-1\"><div class=\"tabtitlelabel\">2021-2023<\/div><\/button><button class=\"t-btn\" aria-selected=\"false\" role=\"tab\" tabindex=\"-1\" id=\"gspb-tab-item-btn-gsbp-d8e9962-2\" aria-controls=\"gspb-tab-item-content-gsbp-d8e9962-2\"><div class=\"tabtitlelabel\">2024<\/div><\/button><\/div><div class=\"t-panel-container\"><div class=\"gswipertabs\"><div class=\"swiper-wrapper\">\n<div aria-labelledby=\"gspb-tab-item-btn-gsbp-d8e9962-0\" id=\"gspb-tab-item-content-gsbp-d8e9962-0\" role=\"tabpanel\" tabindex=\"0\" class=\"t-panel swiper-slide active\"><div class=\"wp-block-greenshift-blocks-tab\">\n<h4 class=\"wp-block-heading\" id=\"2017-1\"><strong>2017<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mar 2017<\/strong><br><em>CytoArm filed a US provisional patent application for its revolutionary Armed-T technology.<\/em><\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2018-1\"><strong>2018<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mar 2018<\/strong><br><em>CytoArm filed a Patent Cooperation Treaty (PCT) Application with the World Intellectual Property Organization (WIPO) to protect its T-cell therapy innovations globally.<\/em><\/li>\n\n\n\n<li><strong>Mar 2018<\/strong><br><em>Patent application submitted to the Taiwan Intellectual Property Office (R.O.C). Total: 1 PCT, 2 Patent applications.<\/em><\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2019-1\"><strong>2019<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sep 2019<\/strong><br><em>Patent filed with the Australian IP Office, marking further global expansion of CytoArm\u2019s patent strategy. Total: 1 PCT, 3 Patent applications.<\/em><\/li>\n\n\n\n<li><strong>Sep 2019<\/strong><br><em>Patents filed with the European Patent Office and China National Intellectual Property Administration. Total: 1 PCT, 4 Patent applications.<\/em><\/li>\n\n\n\n<li><strong>Sep 2019<\/strong><br><em>Patent filed with the Japan Patent Office. Total: 1 PCT, 5 Patent applications.<\/em><\/li>\n\n\n\n<li><strong>Sep 2019<\/strong><br><em>Patent filed with the United States Patent and Trademark Office. Total: 1 PCT, 6 Patent applications.<\/em><\/li>\n\n\n\n<li><strong>Oct 2019<\/strong><br><em>Patent filed with the Korean Intellectual Property Office. Total: 1 PCT, 7 Patent applications.<\/em><\/li>\n\n\n\n<li><strong>Nov 2019<\/strong><br><em>First granted patent from the Taiwan Intellectual Property Office. Total: 1 PCT, 6 Patent applications, 1 Patent Granted.<\/em><\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2020-1\"><strong>2020<\/strong><\/h4>\n\n\n\n<p><strong>Nov 2020<\/strong><br><em>Divisional patent granted by Taiwan Intellectual Property Office. Total: 1 PCT, 6 Patent applications, 2 Patents Granted.<\/em><\/p>\n\n\n\n<p><strong>Mar 2020<\/strong><br><em>CytoArm filed a new US provisional patent application.<\/em><\/p>\n<\/div><\/div>\n\n\n\n<div aria-labelledby=\"gspb-tab-item-btn-gsbp-d8e9962-1\" id=\"gspb-tab-item-content-gsbp-d8e9962-1\" role=\"tabpanel\" tabindex=\"0\" class=\"t-panel swiper-slide\"><div class=\"wp-block-greenshift-blocks-tab\">\n<h4 class=\"wp-block-heading\" id=\"2021-1\"><strong>2021<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mar 2021<\/strong><br><em>CytoArm filed a second PCT Application with WIPO, further expanding its international patent coverage.<\/em><\/li>\n\n\n\n<li><strong>Mar 2021<\/strong><br><em>Patents filed with the Taiwan Intellectual Property Office and Japan Patent Office. Total: 2 PCT, 7 Patent applications, 2 Patents Granted.<\/em><\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2022-1\"><strong>2022<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Feb 2022<\/strong><br><em>Patent granted by the Korean Intellectual Property Office. Total: 2 PCT, 6 Patent applications, 3 Patents Granted.<\/em><\/li>\n\n\n\n<li><strong>Feb 2022<\/strong><br><em>Divisional patent filed with the Australian IP Government. Total: 2 PCT, 7 Patent applications, 3 Patents Granted.<\/em><\/li>\n\n\n\n<li><strong>Mar 2022<\/strong><br><em>Patent granted by the Japan Patent Office. Total: 2 PCT, 6 Patent applications, 4 Patents Granted.<\/em><\/li>\n\n\n\n<li><strong>May 2022<\/strong><br><em>Patent granted by the Australian IP Government. Total: 2 PCT, 5 Patent applications, 5 Patents Granted.<\/em><\/li>\n\n\n\n<li><strong>Aug 2022<\/strong><br><em>CytoArm filed its third PCT Application, further enhancing global intellectual property protection.<\/em><\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2023-1\"><strong>2023<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Dec 2023<\/strong><br><em>Continuation In-Part Patent filed with the United States Patent and Trademark Office.<\/em><\/li>\n<\/ul>\n<\/div><\/div>\n\n\n\n<div aria-labelledby=\"gspb-tab-item-btn-gsbp-d8e9962-2\" id=\"gspb-tab-item-content-gsbp-d8e9962-2\" role=\"tabpanel\" tabindex=\"0\" class=\"t-panel swiper-slide\"><div class=\"wp-block-greenshift-blocks-tab\">\n<h4 class=\"wp-block-heading\" id=\"2024-1\"><strong>2024<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Feb 2024<\/strong><br><em>Patent granted by the United States Patent and Trademark Office, further strengthening CytoArm\u2019s intellectual property in the U.S.<\/em><\/li>\n\n\n\n<li><strong>Mar 2024<\/strong><br><em>Patent filed with the European Patent Office. Total: 3 PCT, 15 Patent applications, 6 Patents Granted.<\/em><\/li>\n<\/ul>\n<\/div><\/div>\n<\/div><\/div><\/div><\/div>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ongoing-and-future-patents\"><strong>Ongoing and Future Patents<\/strong><\/h3>\n\n\n\n<p>CytoArm continues to expand its global patent portfolio, ensuring comprehensive protection of our <strong>Armed-T platform<\/strong> and innovative therapies. Stay tuned for updates on our latest patent filings and newly granted patents, as we continue to push the boundaries of cancer immunotherapy.<\/p>\n\n\n\n<p><strong>Reference: <\/strong>2024 PCT 157 Contracting States, https:\/\/www.wipo.int\/pct\/en\/pct_contracting_states.html<\/p>","protected":false},"excerpt":{"rendered":"<p>CytoArm&#8217;s Global Patent Portfolio At CytoArm, we are pioneering innovative cancer treatment solutions through our Armed-T platform. Our expansive and growing patent portfolio demonstrates the strength and uniqueness of our cutting-edge technology. Below are key milestones showcasing our global patent filings, approvals, and successes. Patent Filing and Approval Milestones Ongoing and Future Patents CytoArm continues [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1113,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_gspb_post_css":"@keyframes gcwidthleftright{0%{width:0%}to{width:100%}}@keyframes gcslidefromtop{0%{transform:translateY(-10px);opacity:0}to{transform:translateY(0);opacity:1}}.gspb-tabs *{box-sizing:border-box!important}.t-btn-container{display:flex;flex-direction:row;width:100%;align-items:center;margin-bottom:-1px;flex-wrap:wrap}.t-btn-container .t-btn{background-origin:border-box;list-style:none;display:inline-flex;align-items:center;margin:0;padding:11px 24px;cursor:pointer;position:relative;transition:all .4s ease-in-out;font-size:20px}.t-btn-container .t-btn .tabsubtitle{font-size:70%;opacity:.7}.gstabs-tabs .t-btn{border:1px solid transparent;border-top-width:2px}.gstabs-tabs .t-btn:focus{outline:0}.gstabs-tabs .t-btn.active{border-color:rgba(206,206,206,.4);border-bottom-color:#fff;background-color:#fff;color:#333}.t-panel-container .t-panel{opacity:0;overflow:hidden;display:none}.t-panel-container .t-panel.active{opacity:1;display:block!important}.t-panel-container{margin-bottom:25px;overflow:hidden;padding:30px}.gstabs-tabs .t-panel-container{border:1px solid rgba(206,206,206,.4);background-color:#fff}.t-btn-container ul{margin:0!important;padding:0!important}.gstabs-underline .t-btn-container .t-btn:after{position:absolute;bottom:0;left:0;content:'';height:3px;width:0;transition:width .5s,left .5s,right .5s}.gstabs-underline .t-btn-container .t-btn.active:after{width:100%;left:0;right:0}.gstabs-pills .t-btn-container .t-btn{margin:0 10px;border:1px solid transparent}.gstabs-vertical{display:flex}.gstabs-vertical .t-btn-container{display:block;width:150px}.gstabs-vertical .t-btn-container .t-btn{margin-bottom:10px;width:150px;border:1px solid transparent}.gstabs-vertical .t-panel-container{flex-grow:1}.t-btn-container .t-btn .gs-image{flex-grow:inherit}.t-btn-container .t-btn img{margin:0;height:25px;min-width:auto}@media (max-width:575.98px){body .tabscroll .t-btn-container{overflow-x:scroll;flex-wrap:nowrap;scroll-behavior:smooth;scroll-snap-type:x mandatory;width:100%!important;white-space:nowrap;display:block;padding-bottom:15px}.tabscroll .t-btn-container .t-btn{scroll-snap-align:start;white-space:nowrap;width:auto!important;margin-right:10px}.tabscroll .t-btn-container .t-btn.active{box-shadow:none!important}.gstabs-vertical{display:block!important}.gstabs-vertical .t-panel-container{margin-top:25px}.t-btn-container .t-btn{font-size:15px}}.gswipertabs{overflow:hidden}.t-panel-container .t-panel{width:100%}.t-panel-container p:last-of-type{margin-bottom:0}.gspb_tabs-id-gsbp-d8e9962 .t-btn-container{justify-content:left}.gspb_tabs-id-gsbp-d8e9962>.t-btn-container>.t-btn{background-color:#f5f5f5}.gspb_tabs-id-gsbp-d8e9962>.t-btn-container>.t-btn.active{background-color:#e5e5e5}.gspb_tabs-id-gsbp-d8e9962 .t-btn-container .t-btn{gap:10px}","footnotes":""},"categories":[19],"tags":[],"class_list":["post-1108","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patent"],"blocksy_meta":{"page_structure_type":"default","disable_featured_image":"no","styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":6}},"_links":{"self":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/posts\/1108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/comments?post=1108"}],"version-history":[{"count":0,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/posts\/1108\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/media\/1113"}],"wp:attachment":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/media?parent=1108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/categories?post=1108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/tags?post=1108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}